Boehringer Ingelheim presents strong lung cancer portfolio and...
www.businesswire.com
Boehringer Ingelheim today announced that the latest data from its oncology portfolio will be presented at the ESMO Asia Congress in Singapore, 1
GLORIA — GEOMAR Library Ocean Research Information Access
geomar-search.kobv.de
pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from ...
Efficacy Study of Temsirolimus to Treat Head and Neck Cancer |...
www.deepdyve.com
Recruiting. Thomas Gauler, MD. + Thomas Gauler, MD. Principal Investigator. Universitätsklinikum Halle Clinic ...
Long-term survival of patients with central or > 7 cm T4 N
ro-journal.biomedcentral.com
by N Guberina · — Nika Guberina, Christoph Pöttgen, Maja Guberina, Thomas Gauler & Martin Stuschke. Department of Medical Oncology, West German Cancer Center, ... › articles
pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients...
link.springer.com
Background The role of pERK, pAKT and p53 as biomarkers in patients with advanced pancreatic cancer has not yet been defined.
Prediction of malignant lymph nodes in NSCLC by machine ...
www.nature.com
by M Guberina · — Maja Guberina, Christoph Pöttgen, Nika Guberina, Thomas Gauler, Alina Santiago Garcia & Martin Stuschke. German Cancer Consortium (DKTK), ... › scientific reports › articles
All web results to the name "Thomas Gauler"
Download Figures (PPT) - European Journal of Cancer
www.ejcancer.com
... Martin Metzenmacher, Dirk Theegarten, Thomas Gauler, Karl-Heinz Jöckel, Kaid Darwiche, Clemens Aigner, Martin Stuschke, Wilfried E. Eberhardt. › article › ppt
Effectiveness of durvalumab consolidation in stage III non ...
www.futuremedicine.com
by M Guberina · — Thomas Gauler. Department of Radiotherapy, West German Cancer Center, University Hospital Essen, EssenGermany. › abs › imt
Novel strategies in molecular targeted therapy of mesothelioma
www.jto.org
by S Korfee · · Cited by 1 — Thomas Gauler. Thomas Gauler. Affiliations. Dept. of Internal Medicine (Cancer Res.), West German Cancer Centre, University Hospital of the University of ... › article › fulltext
Preliminary results in non-small cell lung cancer (NSCLC)
www.ejradiology.com
Philipp Heusch, Jens Köhler, Hans-Joerg Wittsack, Till A. Heusner, Christian Buchbender, Thorsten D. Poeppel, Felix Nensa, Axel Wetter, Thomas Gauler, ... › article › ppt
Boehringer Ingelheim presents strong lung cancer portfolio ...
www.yahoo.com
Boehringer Ingelheim presents strong lung cancer portfolio and long-awaited head-to-head data of afatinib compared to ... Thomas Gauler, Didier Cupissol, Juan ...
Individual profiling of circulating tumor cell composition in...
tlcr.amegroups.com
Individual profiling of circulating tumor cell composition in patients with non-small cell lung cancer receiving platinum based treatment
Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer |...
www.rxwiki.com
Contact: Thomas Gauler, MD | + Principal Investigator: Thomas Gauler, MD. Recruiting. Universitatsklinikum Hamburg-Eppendorf: Hamburg, Germany,
Detection of Circulating Tumor Cell Subpopulations in Patients with...
journals.plos.org
Thomas Gauler, Affiliation: Molecular Oncology Risk-Profile Evaluation, Department of Medical Oncology, West German Cancer Center, University Duisburg-Essen
Using endobronchial valves to reduce irradiation portals in lung...
www.infona.pl
Thomas Gauler. Internal Medicine/Cancer Research, University Hospital Essen, University of Duisburg-Essen, Germany ...
Related search requests for Thomas Gauler
Juan José Grau Maja Guberina Clemens Aigner | Helmut Teschler Andreas Bockisch Eleni Gkika | Britta Graupner Nika Guberina José Grau |
People Forename "Thomas" (109888) Name "Gauler" (17) |
sorted by relevance / date